Publication: Guideline for the Pharmacotherapy of Treatment-Resistant Schizophrenia
| dc.contributor.author | Chamlong Disayavanish | en_US |
| dc.contributor.author | Pichet Udomratn | en_US |
| dc.contributor.author | Duangjai Kasantikul | en_US |
| dc.contributor.author | Thienchai Ngamtipwatthana | en_US |
| dc.contributor.author | Poonsri Rangseekajee | en_US |
| dc.contributor.author | Pramote Sukanich | en_US |
| dc.contributor.author | Taweesin Visanuyothin | en_US |
| dc.contributor.author | Manit Srisurapanont | en_US |
| dc.contributor.author | Primprao Disayavanish | en_US |
| dc.contributor.author | Pongsatorn Netrakom | en_US |
| dc.contributor.author | Srichan Phornchirasilp | en_US |
| dc.contributor.author | Paitoon Samuthrsindh | en_US |
| dc.contributor.author | Kittiwan Thiam-Kaew | en_US |
| dc.contributor.other | Chiang Mai University | en_US |
| dc.contributor.other | Prince of Songkla University | en_US |
| dc.contributor.other | Chulalongkorn University | en_US |
| dc.contributor.other | Phramongkutklao College of Medicine | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.contributor.other | Khon Kaen University | en_US |
| dc.contributor.other | Srithanya Hospital | en_US |
| dc.contributor.other | Suanprung Psychiatric Hospital | en_US |
| dc.contributor.other | Somdet Chaopraya Hosp. | en_US |
| dc.date.accessioned | 2018-09-07T09:24:51Z | |
| dc.date.available | 2018-09-07T09:24:51Z | |
| dc.date.issued | 2000-01-01 | en_US |
| dc.description.abstract | The authors proposed to develop an evidence-based guideline relevant to drug use for treatment-resistant schizophrenia (TRS), which will be called "Guideline for the Pharmacotherapy of Treatment-Resistant Schizophrenia or PTRS Guideline". The authors performed a MEDLINE search (between 1966 and December 1998) and classified the study designs of those trials by using the system proposed by the Agency for Health Care Policy and Research (AHCPR). The levels of evidence were graded and recommendations were made by the use of a system modified from that of the AHCPR. One hundred and sixty-three articles met the inclusion criteria for the review. For a schizophrenic patient who does not respond to a classical antipsychotic. | en_US |
| dc.identifier.citation | Journal of the Medical Association of Thailand. Vol.83, No.6 (2000) | en_US |
| dc.identifier.issn | 01252208 | en_US |
| dc.identifier.other | 2-s2.0-0347113400 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/26353 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0347113400&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Guideline for the Pharmacotherapy of Treatment-Resistant Schizophrenia | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0347113400&origin=inward | en_US |
